Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon signs Provenge supply deal with Glaxo
Bizjournals.com
Tuesday, September 21, 2010 - 1:17pm
tags:
Dendreon, Provenge, GSK, prostate cancer, vaccines
Vivus: Weight Loss Extends Two Years
TheStreet.com
Tuesday, September 21, 2010 - 12:07pm
tags:
obesity, Vivus, Qnexa
Watch for Continued Gains in Shares of Medicis Pharmaceutical
Comtex Smartrend
Tuesday, September 21, 2010 - 12:06pm
tags:
Medicis
Chelsea Therapeutics Shares Fly on Hypotension Drug Trials Promise
Seeking Alpha
Tuesday, September 21, 2010 - 12:02pm
tags:
hypotension, Chelsea Therapeutics, Northera
Merck KGaA Sees Single-Digit Serono Sales Growth as Erbitux Revenue Rises
Bloomberg
Tuesday, September 21, 2010 - 12:00pm
tags:
Merck KGaA, Merck Serono, Erbitux
Ranbaxy Has Sole Approval to Sell Generic Aricept in U.S., Regulator Says
Bloomberg
Tuesday, September 21, 2010 - 11:59am
tags:
Ranbaxy, Aricept, generics, Eisai, Alzheimer's disease
Santarus: A Stock With Potential to Run
Seeking Alpha
Tuesday, September 21, 2010 - 11:16am
tags:
Santarus, Zegerid, Glumetza
Fewer Docs Use ‘Closed’ Web Sites To Swap Info
Pharmalot
Tuesday, September 21, 2010 - 11:15am
tags:
physicians
Novartis Aims for China Trial of Novel Cancer Drug in 2013
Seeking Alpha
Tuesday, September 21, 2010 - 11:14am
tags:
Novartis, China, cancer
Dapagliflozin: Potential Blockbuster, No Me-Too About It
Motley Fool
Tuesday, September 21, 2010 - 11:13am
tags:
diabetes, Bristol-Myers Squibb, Dapagliflozin, AstraZeneca
Abbott to cut 3,000 jobs following Solvay deal
Yahoo/AP
Tuesday, September 21, 2010 - 11:10am
tags:
layoffs, Abbott Laboratories, Solvay, M&A
Have pharmaceutical representatives been expected to fill label claim and data voids?
Pharmareform
Tuesday, September 21, 2010 - 9:24am
tags:
drug reps, physicians
U.S. panel backs Boehringer drug to reduce strokes
Reuters
Tuesday, September 21, 2010 - 9:20am
tags:
FDA, advisory panels, stroke, Boehringer Ingelheim, Pradaxa, blood thinners
Novartis' Multiple Sclerosis Drug Gilenia Poised for Approval
Minyanville
Tuesday, September 21, 2010 - 9:19am
tags:
Novartis, Gilenia, FDA, MS, multiple sclerosis
Sanofi-Aventis says diabetics had better blood sugar control with Lantus versus alternatives
Yahoo/AP
Tuesday, September 21, 2010 - 9:16am
tags:
Sanofi, diabetes, Lantus, insulin, Bristol-Myers Squibb
Pfizer Wants to Be the IBM of Animal Health
WSJ Online
Tuesday, September 21, 2010 - 9:15am
tags:
Pfizer, animal health
AstraZeneca Urges Increase in FDA Funding
Yahoo
Tuesday, September 21, 2010 - 9:14am
tags:
FDA, AstraZeneca
The Catalysts That Will Propel Cyclacel Pharmaceuticals Higher
Seeking Alpha
Monday, September 20, 2010 - 12:39pm
tags:
Cyclacel
Chelsea rallies on data; drug-sector indexes rise
Marketwatch
Monday, September 20, 2010 - 12:37pm
tags:
Chelsea Therapeutics, drug stocks, Northera
FDA Schedules Meeting on Biosimilars
TheStreet.com
Monday, September 20, 2010 - 12:20pm
tags:
FDA, biosimilars

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.